The landscape of dementia prognosis has developed substantially with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-based mostly exams that could detect Alzheimer's pathology a long time just before signs and symptoms arise. Though these technological innovations characterize impressive progress in understanding neurodegenerative disorders, https://williama085xhp4.wikisona.com/user